Mara Santilli

1 week ago | theflowspace.com | Mara Santilli

Wendy Williams, 60, most famous for her long-running talk show The Wendy Williams Show, is currently fighting for her health and autonomy. In the past, she’s been open on her show about her health issues, including substance use disorder and autoimmune conditions Grave’s disease and lymphedema.

2 weeks ago | theflowspace.com | Mara Santilli

Vegamour GRO+ Advanced Complete SystemThis one’s a splurge, but worth it because it nourishes both the hair follicles, strands and the scalp. “The Vegamour GRO+ Advanced line can be very helpful for supporting healthier hair growth, cleansing and nourishing the hair and scalp while also infusing it with peptides and plant extracts, like red clover and turmeric, to help prevent shedding and strengthen the follicle,” says Yadav.

2 weeks ago | yahoo.com | Mara Santilli

All products and services featured are independently chosen by editors. However, Flow Space may receive a commission on orders placed through its retail links, and the retailer may receive certain auditable data for accounting purposes. When you think about your skin care and sun care routines, your scalp is probably not the first thing that comes to mind. You might not even notice your scalp until the next time you reach for your blow-dry brush.

2 weeks ago | theflowspace.com | Mara Santilli

While breast cancer mortality rates have steadily decreased across the board, breast cancer incidence rates are still trending upward, especially in women under 50, per recent . Plus, disparities in breast cancer care access and mortality rates persist in Asian American and Pacific Islander women, Black women and Native American women. Because of the uptick in diagnoses, experts have recommended changes in breast cancer screening and mammogram guidelines over the past year.

2 weeks ago | theflowspace.com | Lauryn Higgins |Mara Santilli

UPDATE: It’s Now Possible to Get an Alzheimer’s Blood Test in Your Doctor’s OfficeThe FDA has just granted expedited approval for the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, a test that can help predict an Alzheimer’s diagnosis. It can screen for two proteins, p-tau 217 and beta amyloid, that indicate the presence of amyloid plaques in the brain, which are the protein deposits that settle in between nerve cells and cause cognitive damage.